APO Research
Talk to an analyst

APO RESEARCH · REPORT

Levodopa and Benserazide Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Levodopa and Benserazide Hydrochloride Capsules Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchLevodopa and Benserazide Hydrochloride Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Levodopa and Benserazide Hydrochloride Capsules Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Levodopa and Benserazide Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levodopa and Benserazide Hydrochloride Capsules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Levodopa and Benserazide Hydrochloride Capsules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Levodopa and Benserazide Hydrochloride Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Levodopa and Benserazide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Levodopa and Benserazide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Levodopa and Benserazide Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Levodopa and Benserazide Hydrochloride Capsules include Shanghai Sine Pharmaceutical, Roche, Guangzhou Baiyunshan Pharmaceutical, Teva GmbH and Hexal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Levodopa and Benserazide Hydrochloride Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Levodopa and Benserazide Hydrochloride Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Levodopa and Benserazide Hydrochloride Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Levodopa and Benserazide Hydrochloride Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Levodopa and Benserazide Hydrochloride Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Levodopa and Benserazide Hydrochloride Capsules Market by Company

Shanghai Sine Pharmaceutical

Roche

Guangzhou Baiyunshan Pharmaceutical

Teva GmbH

Hexal

Levodopa and Benserazide Hydrochloride Capsules Segment by Type

Original Drug

Generic Drug

Levodopa and Benserazide Hydrochloride Capsules Segment by Application

Hospital and Clinic

Pharmacy

Levodopa and Benserazide Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levodopa and Benserazide Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levodopa and Benserazide Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levodopa and Benserazide Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Levodopa and Benserazide Hydrochloride Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Levodopa and Benserazide Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Levodopa and Benserazide Hydrochloride Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Levodopa and Benserazide Hydrochloride Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Levodopa and Benserazide Hydrochloride Capsules Industry Trends Table 25. Levodopa and Benserazide Hydrochloride Capsules Industry Drivers Table 26. Levodopa and Benserazide Hydrochloride Capsules Industry Opportunities and Challenges Table 27. Levodopa and Benserazide Hydrochloride Capsules Industry Restraints Table 28. Global Levodopa and Benserazide Hydrochloride Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Levodopa and Benserazide Hydrochloride Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Levodopa and Benserazide Hydrochloride Capsules Sales Share by Company (2021-2026) Table 32. Global Levodopa and Benserazide Hydrochloride Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Levodopa and Benserazide Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Levodopa and Benserazide Hydrochloride Capsules Major Company Production Sites and Headquarters Table 35. Global Levodopa and Benserazide Hydrochloride Capsules Company, Product Type & Application Table 36. Global Levodopa and Benserazide Hydrochloride Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Levodopa and Benserazide Hydrochloride Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Levodopa and Benserazide Hydrochloride Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Levodopa and Benserazide Hydrochloride Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Levodopa and Benserazide Hydrochloride Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Sine Pharmaceutical Company Information Table 72. Shanghai Sine Pharmaceutical Business Overview Table 73. Shanghai Sine Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Shanghai Sine Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Product Portfolio Table 75. Shanghai Sine Pharmaceutical Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Roche Levodopa and Benserazide Hydrochloride Capsules Product Portfolio Table 80. Roche Recent Development Table 81. Guangzhou Baiyunshan Pharmaceutical Company Information Table 82. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 83. Guangzhou Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangzhou Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Product Portfolio Table 85. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 86. Teva GmbH Company Information Table 87. Teva GmbH Business Overview Table 88. Teva GmbH Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Teva GmbH Levodopa and Benserazide Hydrochloride Capsules Product Portfolio Table 90. Teva GmbH Recent Development Table 91. Hexal Company Information Table 92. Hexal Business Overview Table 93. Hexal Levodopa and Benserazide Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hexal Levodopa and Benserazide Hydrochloride Capsules Product Portfolio Table 95. Hexal Recent Development Table 96. North America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 98. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 99. North America Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 101. North America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Levodopa and Benserazide Hydrochloride Capsules Market Share by Country (2021-2026) Table 104. North America Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Levodopa and Benserazide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 106. Europe Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 108. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 109. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Levodopa and Benserazide Hydrochloride Capsules Market Share by Country (2021-2026) Table 114. Europe Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Levodopa and Benserazide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Share by Country (2021-2026) Table 124. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 126. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 128. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 129. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Share by Country (2021-2026) Table 134. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Share by Country (2021-2026) Table 144. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Levodopa and Benserazide Hydrochloride Capsules Distributors List Table 149. Levodopa and Benserazide Hydrochloride Capsules Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Levodopa and Benserazide Hydrochloride Capsules Image Figure 2. Global Levodopa and Benserazide Hydrochloride Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levodopa and Benserazide Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Levodopa and Benserazide Hydrochloride Capsules Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Levodopa and Benserazide Hydrochloride Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Levodopa and Benserazide Hydrochloride Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Levodopa and Benserazide Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Levodopa and Benserazide Hydrochloride Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Levodopa and Benserazide Hydrochloride Capsules Market Share by Application 2025 VS 2032 Figure 29. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 30. North America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 31. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 32. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 35. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 39. North America Levodopa and Benserazide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Levodopa and Benserazide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Levodopa and Benserazide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Levodopa and Benserazide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Levodopa and Benserazide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Levodopa and Benserazide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Levodopa and Benserazide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Levodopa and Benserazide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Levodopa and Benserazide Hydrochloride Capsules Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Levodopa and Benserazide Hydrochloride Capsules Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Shanghai Sine Pharmaceutical
  • Roche
  • Guangzhou Baiyunshan Pharmaceutical
  • Teva GmbH
  • Hexal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Levodopa and Benserazide Hydrochloride Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Levodopa and Benserazide Hydrochloride Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Levodopa and Benserazide Hydrochloride Capsules Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Levodopa and Benserazide Hydrochloride Capsules Market Size by Type
  9. 1.4.1 Global Levodopa and Benserazide Hydrochloride Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Levodopa and Benserazide Hydrochloride Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Levodopa and Benserazide Hydrochloride Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Levodopa and Benserazide Hydrochloride Capsules Industry Trends
  2. 2.2 Levodopa and Benserazide Hydrochloride Capsules Industry Drivers
  3. 2.3 Levodopa and Benserazide Hydrochloride Capsules Industry Opportunities and Challenges
  4. 2.4 Levodopa and Benserazide Hydrochloride Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Levodopa and Benserazide Hydrochloride Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Levodopa and Benserazide Hydrochloride Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Levodopa and Benserazide Hydrochloride Capsules Price (2021-2026)
  4. 3.4 Global Levodopa and Benserazide Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Levodopa and Benserazide Hydrochloride Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Levodopa and Benserazide Hydrochloride Capsules Company, Product Type & Application
  7. 3.7 Global Levodopa and Benserazide Hydrochloride Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Levodopa and Benserazide Hydrochloride Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Levodopa and Benserazide Hydrochloride Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Levodopa and Benserazide Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Levodopa and Benserazide Hydrochloride Capsules Regional Status and Outlook
  1. 4.1 Global Levodopa and Benserazide Hydrochloride Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Levodopa and Benserazide Hydrochloride Capsules Historic Market Size by Region
  3. 4.2.1 Global Levodopa and Benserazide Hydrochloride Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Levodopa and Benserazide Hydrochloride Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Levodopa and Benserazide Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Levodopa and Benserazide Hydrochloride Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Levodopa and Benserazide Hydrochloride Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Levodopa and Benserazide Hydrochloride Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Levodopa and Benserazide Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Levodopa and Benserazide Hydrochloride Capsules by Application
  1. 5.1 Levodopa and Benserazide Hydrochloride Capsules Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Levodopa and Benserazide Hydrochloride Capsules Market Size by Application
  5. 5.2.1 Global Levodopa and Benserazide Hydrochloride Capsules Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Levodopa and Benserazide Hydrochloride Capsules Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Levodopa and Benserazide Hydrochloride Capsules Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Sine Pharmaceutical
  2. 6.1.1 Shanghai Sine Pharmaceutical Company Information
  3. 6.1.2 Shanghai Sine Pharmaceutical Business Overview
  4. 6.1.3 Shanghai Sine Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Sine Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Product Portfolio
  6. 6.1.5 Shanghai Sine Pharmaceutical Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Levodopa and Benserazide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Levodopa and Benserazide Hydrochloride Capsules Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Guangzhou Baiyunshan Pharmaceutical
  14. 6.3.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  15. 6.3.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  16. 6.3.3 Guangzhou Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangzhou Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Capsules Product Portfolio
  18. 6.3.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  19. 6.4 Teva GmbH
  20. 6.4.1 Teva GmbH Company Information
  21. 6.4.2 Teva GmbH Business Overview
  22. 6.4.3 Teva GmbH Levodopa and Benserazide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva GmbH Levodopa and Benserazide Hydrochloride Capsules Product Portfolio
  24. 6.4.5 Teva GmbH Recent Developments
  25. 6.5 Hexal
  26. 6.5.1 Hexal Company Information
  27. 6.5.2 Hexal Business Overview
  28. 6.5.3 Hexal Levodopa and Benserazide Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hexal Levodopa and Benserazide Hydrochloride Capsules Product Portfolio
  30. 6.5.5 Hexal Recent Developments
7 North America by Country
  1. 7.1 North America Levodopa and Benserazide Hydrochloride Capsules Sales by Country
  2. 7.1.1 North America Levodopa and Benserazide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country
  6. 7.2.1 North America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Country
  2. 8.1.1 Europe Levodopa and Benserazide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Levodopa and Benserazide Hydrochloride Capsules Market Size by Country
  6. 8.2.1 Europe Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Levodopa and Benserazide Hydrochloride Capsules Sales by Country
  2. 10.1.1 South America Levodopa and Benserazide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country
  6. 10.2.1 South America Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Levodopa and Benserazide Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Levodopa and Benserazide Hydrochloride Capsules Value Chain Analysis
  2. 12.1.1 Levodopa and Benserazide Hydrochloride Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Levodopa and Benserazide Hydrochloride Capsules Production Mode & Process
  7. 12.2 Levodopa and Benserazide Hydrochloride Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Levodopa and Benserazide Hydrochloride Capsules Distributors
  10. 12.2.3 Levodopa and Benserazide Hydrochloride Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst